Fidelity MSCI Health Care Index ETF FHLC
90.00 USD +0.40 (+0.45%)
Regular-session close
90.00 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
89.25 Day range 90.17
68.53 52-week range 90.77
- YTD
- +21.16%
- 1 year
- +23.15%
News
defenseworld.net Commonwealth Equity Services LLC Buys New Shares in Fidelity MSCI Health Care Index ETF $FHLC Commonwealth Equity Services LLC bought a new position in shares of Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) during the third quarter, according to the company in its most recent 13F…
benzinga.com UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.
benzinga.com White House Reportedly Preparing To Oust FDA Commissioner Marty Makary Trump considers Kyle Diamantas for acting FDA chief as Marty Makary faces potential removal. Stay updated on the leadership transition.
benzinga.com Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations A federal court blocked NIH's policy capping indirect cost rates on research grants, ruling it unlawful. The decision safeguards billions in funding and ongoing clinical trials.
benzinga.com NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.
benzinga.com Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
benzinga.com Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests to detect diseases sooner and personalize treatments.
benzinga.com From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as…- benzinga.com Fidelity Trims Fees on 3 Bond ETFs
benzinga.com Heaps Of Healthy Health Care ETFs - benzinga.com Previewing Fidelity's Upcoming Low Volatility ETF
benzinga.com Fidelity Fires Back At Vanguard With Sector ETF Fee Cuts - benzinga.com The Other Sector ETF Player
- benzinga.com Brokerage Giants Expand In ETF Space
benzinga.com Healthcare ETFs Unmoved By Possible Humana Inc. Merger